Skip to content

Xencor XNCR Change in AR

Change in AR at other companies

Amgen logo
AmgenAMGN
-$413M-132%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$1.2M+99.8%
Janux Therapeutics logo
Janux TherapeuticsJANX
$35M
Absci Corporation logo
Absci CorporationABSI
$0-100%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$0+100%
XER
Xeris Biopharma Holdings, Inc.XERS
$5.25M-11.3%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
Net margin-177.1%+16.5pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's change in AR?
Xencor (XNCR) reported change in AR of -$5.8M in Q1 2026.
How has Xencor's change in AR changed year-over-year?
Xencor's change in AR increased by 75.2% year-over-year, from -$23.41M to -$5.8M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.